Articles
humanin
Evidence is being populated by Grok web
foxo4 dri
Evidence is being populated by Grok web
vip
Evidence is being populated by Grok web
What This Framework Enables: Use Cases Beyond Peptide Catalogues
The body is always doing two things at once: breaking down and building back. A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal without fixing the tissue that caused the signal. This
The Logic of the Logic: Recursive Ledger, Entropy, and Combinatorial Control
The body runs two processes at the same time. One breaks tissue down. One builds it back. A problem stays when the breakdown stays ahead of the repair. Most drugs used for symptoms block a signal without changing the tissue that made the
How Claims Work: Voxel Atoms, Tiers, Weights, and Honesty Gates
The body is always doing two things at once: breaking down and building back. A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal without fixing the tissue that caused the signal. This ledger
cerebrolysin
Evidence is being populated by Grok web
Protocol Widgets: Self-Explanation, Vault Cards, and Native Embeds
The body breaks down tissue and builds it back at the same time. A problem stays when breakdown runs faster than repair. Most drugs block signals such as pain or swelling without fixing the tissue that sent the signal. This ledger studies
Protocol API Structure: REST Surface, Objects, and Phase Machine
The body breaks down tissue and rebuilds it at the same time. A problem lasts when breakdown moves faster than repair. Most drugs block signals such as pain or swelling. They do not rebuild the tissue that created the signal. This article
dihexa
Evidence is being populated by Grok web
ll 37
Evidence is being populated by Grok web
epitalon
Evidence is being populated by Grok web
ss 31
Evidence is being populated by Grok web
mots c
Evidence is being populated by Grok web
miscsubjects article protocol (constitution)
Principle: Self-explaining payload — no external context required. This self block describes what you are reading and where to look next. This widget: articleconstitution — Article constitution Binding rules: required article slots,
DSIP Peptide and Sleep Regulation: Evidence on Delta Sleep-Inducing Peptide
Delta Sleep-Inducing Peptide (DSIP) is a 9-amino-acid neuropeptide first identified in the 1970s. It has been investigated for effects on sleep architecture, primarily in animal models and limited human studies. Small clinical
Semax, DSIP, and Selank: Evidence Review on Mechanisms Related to Cognition, Sleep, and Anxiety
Data on Semax, DSIP, and Selank derive primarily from preclinical models, small human trials (often Russian-language or limited sample size), and mechanistic studies. No human trials examine the combination in Adderall (amphetamine) users
Recovery Stack for Diabetic Neuropathy
The body breaks tissue down and builds tissue back at the same time. Diabetic neuropathy persists when nerve and vessel damage outruns repair. Most drugs for this condition mute pain signals. The compounds in this ledger are studied for
BPC-157 Compared to NSAIDs: Preclinical Data on Gut Protection and Tissue Repair
NSAIDs inhibit COX enzymes to reduce prostaglandin-mediated pain and inflammation (mechanistic). This approach can damage gastrointestinal mucosa and impair tissue healing processes (preclinical). BPC-157 is a gastric juice-derived
Recovery Stack for Opioid Taper Support
Opioids mask pain signals from unrepaired tissue injuries. Tapering unmasks those signals as repair deficits persist. A recovery stack targets tissue repair, inflammation clearance, and nerve regeneration to address pain sources rather
PT-141 + Selank for SSRI Users: Evidence Review
PT-141 is a melanocortin receptor agonist approved by the FDA in 2019 as Vyleesi for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Phase 3 randomized controlled trials demonstrated statistically
Peptide Purity, COAs, and Source Verification
A Certificate of Analysis (COA) is a laboratory document summarizing analytical testing on a specific batch of a research compound, including compound name, batch/lot number, analytical methods, purity results, testing date, and laboratory
BPC-157 and ARA-290: Evidence on Tissue Repair and Nerve Regeneration in Context of Corticosteroid Effects
The body breaks down tissue and rebuilds it at the same time. When breakdown exceeds repair, pain, weakness, and nerve loss persist. Corticosteroid injections reduce inflammation signals but can slow the repair steps that follow. BPC-157
BPC-157 and Stimulant-Associated Gastrointestinal Lining Changes: Evidence Summary
The body breaks tissue down and builds it back at the same time. When breakdown runs ahead, damage stays. Stimulants such as Adderall can suppress appetite. Less food in the stomach may let acid sit against the lining. That is a
tb 500 herniated disc
herniated disc represents tissue breakdown exceeding repair capacity. Most interventions manage symptoms. This article examines whether tb-500 mechanisms address underlying repair deficits. Studied for thymosin beta-4 pathways — cells
BDNF Explained: Brain-Derived Neurotrophic Factor and Brain Repair
The body runs two processes at once: tissue breakdown and tissue repair. When breakdown exceeds repair, conditions persist. Most drugs block signals such as pain or inflammation without restoring the tissue. BDNF sits on the repair side.
Structure-Function Claims vs Clinical Proof: Peptide Evidence Tiers
Structure-function claims describe how a compound supports normal physiology or structure without implying disease treatment. These are permissible under U.S. regulations when supported by mechanistic or preclinical data but require clear
What Are Peptides?
This primer defines peptides as a class of molecules, explains how they differ from proteins and other common substances, and outlines the evidence standards readers should apply when evaluating claims. It focuses on structure,
How to Read a Peptide Study
PubMed is a free database of biomedical literature maintained by the National Library of Medicine. To locate studies, enter key terms such as peptide names or mechanisms into the search box on https://pubmed.ncbi.nlm.nih.gov/ and press
Wolverine Stack for GLP-1 Full Support
GLP-1 drugs slow gastric emptying and reduce appetite. This can produce weight loss. Some of that loss includes lean mass. The body is breaking down tissue faster than it rebuilds. The Wolverine stack (BPC-157 plus TB-500) is discussed as
BPC-157 for Post-Surgery Recovery: Evidence Review
The body breaks down tissue after surgery and must rebuild it. When breakdown outruns repair, recovery stalls. BPC-157 is studied for a repair pathway: it may increase blood vessel growth at the injury site. More blood vessels means more
BPC-157 and Gut Lining Repair: Preclinical Evidence Summary
The body breaks down tissue and builds it back at the same time. When breakdown outruns repair, gut lining damage stays. Most drugs mute pain or acid signals. BPC-157 is studied for a repair path: new blood vessels at the injury site,
BPC-157 for IBD, Crohn's Disease, and Colitis: Preclinical Data and Trial Status
The body breaks down tissue and builds it back at the same time. IBD, Crohn's, and colitis persist when breakdown outpaces repair in the gut lining. Most drugs reduce inflammation signals without rebuilding the damaged wall. BPC-157 is
BPC-157 for Benzodiazepine Withdrawal Gut Support: Evidence Review
Benzodiazepines act on GABA-A receptors present in the enteric nervous system. Withdrawal disrupts this signaling, leading to gut hyperexcitability in preclinical models. Claim (mechanistic): GABA-A receptors in the gut mediate
ARA-290 for Post-Surgical Nerve Damage: Evidence Review
The body breaks down tissue and builds it back at the same time. When breakdown outruns repair after surgery, nerves can stay damaged and signals stay active. ARA-290 is studied for the repair side of this balance in nerve tissue. ARA-290
BPC-157 and ARA-290 for Post-Surgical Nerve Damage: Evidence Summary
The body breaks down tissue and builds it back at the same time. When breakdown outruns repair after surgery, nerve damage can stay. Most drugs reduce pain signals without fixing the nerve itself. BPC-157 and ARA-290 are studied for repair
Recovery Stack for Complex Injuries: BPC-157 + TB-500 + ARA-290
Complex injuries involve overlapping tissue damage, persistent inflammation, and nerve involvement. Standard approaches often target isolated aspects. BPC-157 is a synthetic 15-amino-acid peptide derived from gastric juice protein. In over
Recovery Stack for Chronic Back Pain
Chronic back pain involves tissue degeneration, persistent inflammation, and nerve involvement. BPC-157 targets local tissue repair via angiogenesis. TB-500 addresses systemic cell migration and inflammation clearance. ARA-290 focuses on
BPC-157 + KPV for Gut Lining Repair: Evidence Review
The body breaks down tissue and builds it back at the same time. Gut lining cells die and new cells form. When breakdown runs faster than repair, the lining stays thin, inflamed, or leaky. Most drugs for gut problems lower acid, block
BPC-157 and KPV for IBD, Crohn's Disease, and Colitis: Preclinical Evidence Review
The gut lining breaks down and rebuilds every day. In IBD, Crohn's, and colitis, breakdown outruns repair. Inflammation stays high. Tissue stays damaged. Most drugs lower the inflammation signal but do not fix the lining. BPC-157 and KPV
BPC-157 and KPV: Preclinical Data on Gut Tissue Responses in Relation to Acid Suppression
The body repairs gut lining while acid and inflammation break it down. When repair falls behind, symptoms like reflux or gastritis stay. Acid suppression drugs lower acid signals but do not rebuild tissue. BPC-157 and KPV are studied for
Semax for SSRI Emotional Blunting
SSRIs are associated with emotional blunting in some users, characterized by reduced sensitivity to both positive and negative stimuli (human). A 2019 review noted patients reporting dulled emotions despite reduced pain (human). A 2023
Semax for TBI and Concussion: Evidence Review
Concussion and traumatic brain injury (TBI) involve neuronal damage where endogenous BDNF levels are frequently insufficient for complete recovery (mechanistic). Semax is a synthetic heptapeptide analog of ACTH(4-10) that upregulates BDNF
Recovery Stack for Gabapentin Replacement
Gabapentin reduces how strongly pain signals are felt. It does not heal damaged nerves. Peptides in this ledger are studied for repair pathways. The topic here is whether repair peptides can support tissue recovery where gabapentin only
ARA-290 vs Gabapentin and Lyrica: Human Trial Data on Nerve Repair Versus Signal Suppression
Nerves can break down after injury or disease. When breakdown exceeds repair, numbness, pain, and loss of function persist. Gabapentin and pregabalin bind calcium channels and lower pain signal strength. ARA-290 research examines whether
Selank for Residual Anxiety on SSRIs: Evidence Review
Selank is a synthetic heptapeptide derived from tuftsin with reported anxiolytic properties via non-benzodiazepine pathways. Human data are limited to Russian clinical studies in generalized anxiety disorder (GAD) and related conditions.
PT-141 for SSRI-Induced Sexual Dysfunction: Evidence-Graded Review
SSRIs are linked to loss of libido, anorgasmia, and erectile dysfunction in clinical observations (human tier). Prevalence estimates range 25-73% depending on specific agent and population (human tier). PT-141 (bremelanotide) is a
PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary
PT-141 (bremelanotide) is a melanocortin receptor agonist that activates MC4R pathways in the central nervous system. Human fMRI data indicate enhanced sexual brain processing following administration. Bremelanotide (Vyleesi) received FDA
Thymosin Alpha-1 and Biologic Therapies
Biologic therapies commonly target specific immune pathways, which can result in broad immunosuppression as a side effect. Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide derived from the thymus. Human clinical trials have examined its
GHK-Cu: Collagen Scaffolding and Tissue Remodeling
Plasma GHK levels are approximately 200 ng/mL at age 20 and decline to 80 ng/mL by age 60 (mechanistic; human plasma measurement data). This represents a roughly 60% reduction in circulating GHK (preclinical correlation with age). GHK-Cu